Janus Kinase 3 (JAK3) Peptid
Kurzübersicht für Janus Kinase 3 (JAK3) Peptid (ABIN939905)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- KLLPLDKDYY VVREPGQSPI FWYAPESLSD NIFSRQSDVW SFGVVLYELF
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of JAK3 antibody,
Alternative Names: JAK3 control peptide, JAK3 antibody Blocking Peptide, Anti-JAK3 Blocking Peptide, Janus Kinase 3 Blocking Peptide, JAK-3 Blocking Peptide, JAK3_HUMAN Blocking Peptide, JAKL Blocking Peptide, L-JAK Blocking Peptide, LJAK Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- JAK3 (Janus Kinase 3 (JAK3))
-
Hintergrund
- JAK3 is a member of the Janus kinase (JAK) family of tyrosine kinases, which is involved in cytokine receptor-mediated intracellular signal transduction. JAK3 is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in JAK3 are associated with autosomal SCID (severe combined immunodeficiency disease).
-
Molekulargewicht
- 125 kDa
Target
-